Published in Lancet on December 07, 1968
Lymphocyte sensitization in advanced malignant disease: a study of serum lymphocyte depressive factor. Br J Cancer (1972) 2.46
Immunopathologic studies in relapsing polychondritis. J Clin Invest (1973) 1.98
Inhibition of PHA-stimulated lymphocyte transformation by plasma from patients with advanced alcoholic cirrhosis. Clin Exp Immunol (1971) 1.60
The effect of plasma upon lymphocyte response in vitro. Demonstration of a humoral inhibitor in patients with sarcoidosis. Clin Exp Immunol (1974) 1.51
In vitro cell response of Treponema pallidum-infected rabbits. II. Inhibition of lymphocyte response to phytohaemagglutinin by serum of T. pallidum-infected rabbits. Clin Exp Immunol (1977) 1.43
Demonstration of a blocking factor in the plasma and spinal fluid of patients with subacute sclerosing panencephalitis. I. Partial characterization. J Exp Med (1974) 1.35
Lymphocyte transformation by phytohaemagglutinin (PHA) and purified protein derivative (PPD) in primary biliary cirrhosis. Evidence of serum inhibitory factors. Clin Exp Immunol (1973) 1.25
T and B lymphocytes in multiple sclerosis. Clin Exp Immunol (1975) 1.09
Plasma inhibitors of lymphocyte response to phytohaemagglutinin in children with recurrent infections. Immunology (1976) 1.06
Lymphocyte response depressive factor in multiple sclerosis. Br Med J (1971) 1.05
Immunological studies in acute myeloid leukaemia: PHA responsiveness and serum inhibitory factors. Br J Cancer (1973) 0.90
Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitro. Clin Exp Immunol (1975) 0.89
Immunological dysfunctions in multiple sclerosis. I. Diminution of 'active' thymus-derived lymphocytes and presence of immunomodulating serum factors. Clin Exp Immunol (1979) 0.80
Cold reactive antilymphocyte antibodies in neurological diseases. J Neurol Neurosurg Psychiatry (1979) 0.80
Lymphocyte transformation induced in vitro by PHA and PPD in multiple sclerosis. J Neurol Neurosurg Psychiatry (1970) 0.77
Lymphocyte sensitisation: an in-vitro test for cancer? Lancet (1970) 8.23
Medical student selection: a tentative attempt to establish a code of practice. Br Med J (1980) 7.21
Lymphocyte transformation in vitro measured by tritiated thymidine uptake. I. Lymphocyte culture techniques. Int Arch Allergy Appl Immunol (1970) 5.67
Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia? Br Med J (1971) 5.53
Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science (2000) 4.48
Virulence of antibiotic-resistant Salmonella typhimurium. Proc Natl Acad Sci U S A (1998) 4.28
Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature (1991) 3.86
Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med (1981) 3.85
Consultation length and outcome in two group general practices. J R Coll Gen Pract (1983) 3.76
Brief report: fulminating fat embolism syndrome caused by paradoxical embolism through a patent foramen ovale. N Engl J Med (1993) 3.55
Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr (1997) 3.38
Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1996) 3.20
Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol Microbiol (2001) 2.94
Circulating sensitised lymphocytes in Graves' disease. Observations on its pathogenesis. Lancet (1970) 2.73
Relative ion permeability of normal and cystic fibrosis nasal epithelium. J Clin Invest (1983) 2.72
Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir. Antimicrob Agents Chemother (1998) 2.67
Zika virus infection of the central nervous system of mice. Arch Gesamte Virusforsch (1971) 2.63
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros (2008) 2.56
Paper and people: the work of the casualty reception clerk. Sociol Health Illn (1989) 2.54
Lymphocyte sensitization in advanced malignant disease: a study of serum lymphocyte depressive factor. Br J Cancer (1972) 2.46
Prospective analysis of stoma-related complications. Colorectal Dis (2005) 2.35
Post-traumatic stress disorder in the community: an epidemiological study. Psychol Med (1991) 2.34
Disappointing sensitivity of endoscopic markers for villous atrophy in a high-risk population: implications for celiac disease diagnosis during routine endoscopy. Am J Gastroenterol (2001) 2.30
The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J Exp Med (1997) 2.28
Sensitization of blood lymphocytes to possible antigens in neurological disease. Eur Neurol (1970) 2.19
The connexions of the spinal sub-arachnoid space with the lymphatic system. J Anat (1948) 2.18
Specific laboratory test for diagnosis of multiple sclerosis. Br Med J (1974) 2.17
Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. Nature (1984) 2.14
Electron microscopic observations on the cerebellar cortex in kuru. J Neurol Sci (1969) 2.14
Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature (1993) 2.04
Demonstration of sensitized lymphocytes in blood. J Clin Pathol (1971) 2.04
RCPE UK consensus statement on diabetes. J R Coll Physicians Edinb (2010) 2.03
Comparison of sevoflurane and propofol with rocuronium for modified rapid-sequence induction of anaesthesia. Anaesthesia (1999) 1.98
Letter: A rational prophylactic therapy for multiple sclerosis? Lancet (1973) 1.97
Prevalence of celiac disease and its endoscopic markers among patients having routine upper gastrointestinal endoscopy. Am J Gastroenterol (1999) 1.93
Lymphocyte-antigen interaction in electrophoretic mobility test for cellular sensitization. Nat New Biol (1971) 1.90
Structure of a mutant EF-G reveals domain III and possibly the fusidic acid binding site. J Mol Biol (2000) 1.78
Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals. Mol Cell Biol (1999) 1.77
Geographic variation in the onset of decline of ischemic heart disease mortality in the United States. Am J Public Health (1986) 1.77
Novel ribosomal mutations affecting translational accuracy, antibiotic resistance and virulence of Salmonella typhimurium. Mol Microbiol (1999) 1.75
Unsaturated fatty acids in multiple sclerosis. Br Med J (1973) 1.75
Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J Cell Sci (1994) 1.74
Fusidic acid-resistant mutants define three regions in elongation factor G of Salmonella typhimurium. Gene (1994) 1.74
Lateral spine radiographs before androgen deprivation treatment detect a high incidence of undiagnosed vertebral fragility fractures in men with advanced prostate cancer. J Urol (2011) 1.72
A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum Mol Genet (2001) 1.70
Bolus dose remifentanil for control of haemodynamic response to tracheal intubation during rapid sequence induction of anaesthesia. Br J Anaesth (1999) 1.69
Head injuries: a study evaluating the impact of the NICE head injury guidelines. Emerg Med J (2005) 1.66
The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood (1998) 1.66
Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet (2005) 1.63
Muller's ratchet decreases fitness of a DNA-based microbe. Proc Natl Acad Sci U S A (1996) 1.63
Isolation of Yersinia enterocolitica from milk and a dairy farm in Australia. J Appl Bacteriol (1979) 1.63
Platelet stickiness in multiple sclerosis. Lancet (1965) 1.58
The infective process in scrapie. Lancet (1968) 1.56
Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros (2011) 1.54
Bioelectric properties and ion flow across excised human bronchi. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.52
Lack of mature B cells in nude mice with X-linked immune deficiency. J Exp Med (1982) 1.52
The shifting stroke belt. Changes in the geographic pattern of stroke mortality in the United States, 1962 to 1988. Stroke (1995) 1.51
Transmission experiments with multiple sclerosis: an interim report. Br Med J (1966) 1.51
Increased cholecystectomy rate in the laparoscopic era: a study of the potential causative factors. Surg Endosc (2006) 1.50
Darwin's illness. Lancet (1990) 1.49
Lymphocyte stimulation with muscle homogenate in polymyositis and other muscle-wasting disorders. J Neurol Neurosurg Psychiatry (1969) 1.49
The macrophage electrophoretic migration (MEM) test for lymphocyte sensitization. A study of the kinetics. Clin Exp Immunol (1973) 1.49
Viruses in multiple sclerosis? Lancet (1972) 1.48
"Spontaneous" lymphocyte reactivity in the presence of virus infection. Lancet (1972) 1.48
Community health monitoring: taking the pulse of America's children. Matern Child Health J (1998) 1.47
Activated ras oncogenes in human thyroid cancers. Cancer Res (1988) 1.45
An electron-microscopic study of scrapie in the rat: further observations on "inclusion bodies" and virus-like particles. J Neurol Sci (1972) 1.45
Cellular and humoral responses to measles in subacute sclerosing panencephalitis. Lancet (1969) 1.44
Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. J Clin Microbiol (1997) 1.44
Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology (1994) 1.43
Homologous recombination between the tuf genes of Salmonella typhimurium. J Mol Biol (1996) 1.43
Clinical trial of iron therapy of psychomotor function in anaemic women. Br Med J (1970) 1.41
Lymphocyte sensitization to basic protein of brain in malignant neoplasia: experiments with serotonin and related compounds. Nature (1971) 1.41
Invasion of neurones in vitro by non immune lymphocytes. An electron microscopic study. Br J Exp Pathol (1968) 1.41
The mechanism of antigen-induced electrophoretic mobility reduction of guinea-pig macrophages. Clin Exp Immunol (1972) 1.40
Low-dose clonidine infusion during labour. Br J Anaesth (1999) 1.40
Lymphocyte sensitization in sarcoidosis. Br Med J (1971) 1.39
Use of hyperbaric oxygen in rheumatic diseases: case report and critical analysis. Lupus (1995) 1.39
Benign vaginal polyp: a histological, histochemical and immunohistochemical study of 20 polyps with comparison to normal vaginal subepithelial layer. Histopathology (1992) 1.38
Is midwifery safe in the embrace of the UKCC? Midwives (1995) (1995) 1.38
Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study. Arch Intern Med (1991) 1.38
Purification and properties of a lymphocyte inhibition factor from human serum. Clin Exp Immunol (1973) 1.37
Sequence heterogeneity and anomalous electrophoretic mobility of kinetoplast minicircle DNA from Leishmania tarentolae. Gene (1984) 1.36
Lymphocyte trnsformation induced by encephalitogenic factor in multiple sclerosis and other neurological diseases. Lancet (1968) 1.36